APA (7th ed.) Citation

A, W., JJ, M., SW, F., DJ, F., SR, R., XP, Z., . . . O, B. (2018). MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers. Oncogenesis, 7(4), 35. https://doi.org/10.1038/s41389-018-0043-9

Chicago Style (17th ed.) Citation

A, Wyce, et al. "MEK Inhibitors Overcome Resistance to BET Inhibition Across a Number of Solid and Hematologic Cancers." Oncogenesis 7, no. 4 (2018): 35. https://doi.org/10.1038/s41389-018-0043-9.

MLA (9th ed.) Citation

A, Wyce, et al. "MEK Inhibitors Overcome Resistance to BET Inhibition Across a Number of Solid and Hematologic Cancers." Oncogenesis, vol. 7, no. 4, 2018, p. 35, https://doi.org/10.1038/s41389-018-0043-9.